Large Cap Healthcare Stocks are Mixed Today

Large cap healthcare stocks are mixed today.  Following are some of the stories moving these stocks today.

  • Pfizer, Inc. (NYSE:PFE): The company’s shares were downgraded today by Standpoint Research.  The shares recently traded at $20.03, up $0.16, or 0.83%, on the day.  The shares have traded in a 52-week range of $16.25 to $21.45 and its market capitalization is $156.43 billion.   About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ):  The shares recently traded at $64.80, up $0.80, or 1.25%, on the day.  The shares have traded in a 52-week range of $57.50 to $68.05 and its market capitalization is 4177.55 billion.  About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Amgen, Inc. (NASDAQ:AMGN):  The shares recently traded at $57.81, down $0.62, or 1.06%, on the day.  The shares have traded in a 52-week range of $47.66 to $61.53 and its market capitalization is $50.81 billion.  The company recently announced a $5 billion stock buyback.  About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Vertex Pharmaceuticals (NASDAQ:VRTX): The shares recently traded at $30.50, down $2.72, or 8.13%, on the day.  The shares have traded in a 52-week range of $30.18 to $58.87 and its market capitalization is $6.34 billion.  About the company: Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases.
  • Merck & Co., Inc. (NYSE:MRK): The company reported third quarter net income of $1.69 billion, or $0.55 per share.  The shares recently traded at $34.38, up $0.05 ,or 0.15%, on the day.  The shares have traded in a 52-week range of $29.47 to $37.65 and its market capitalization is $105.92 billion.    About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

Check out our analysis of Jim Cramer’s latest stock calls

More from The Cheat Sheet